Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

NCT00198536 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: Ecabet 2.83%
DRUG: Ecabet 3.70%
DRUG: Vehicle

Sponsor

Bausch & Lomb Incorporated